Early Promise for PI3K Inhibitor in Brain Metastases

(MedPage Today) -- HOUSTON -- Two-thirds of patients with PI3K-mutant brain metastases responded to the maximum tolerated dose (MTD) of the small-molecule inhibitor paxalisib plus radiation therapy (RT), a small phase I study showed.
Eight of...